In the present manuscript, the possible role of BCP in COVID-19 has been proposed based on the previously reported potent pharmacological activity of BCP against infection, inflammation, and immunity in experimental models of human diseases other than SARS-CoV-2. Here, OPN1SW is linked to infection.